The most popular repair peptide combination: BPC-157 + TB-500 co-lyophilized in one vial. Two complementary tissue repair mechanisms — NO/VEGF signaling + actin-mediated cell migration — for synergy research.
The BPC-157 + TB-500 Blend combines two of the most extensively published tissue repair peptides in a single co-lyophilized preparation. BPC-157 (pentadecapeptide from gastric juice protein) and TB-500 (synthetic Thymosin Beta-4) operate through complementary and non-overlapping molecular mechanisms, providing a research model for investigating potential synergistic interactions in tissue repair biology.
BPC-157 primarily modulates growth factor signaling pathways: VEGF and VEGFR2 upregulation driving angiogenesis, FAK-paxillin pathway activation promoting focal adhesion formation and cell spreading, and NO system modulation through both eNOS and iNOS. TB-500 primarily drives cytoskeletal-dependent processes: G-actin sequestration regulating actin polymerization dynamics, promotion of cell migration through cytoskeletal reorganization, and anti-fibrotic activity via the N-terminal Ac-SDKP domain that inhibits collagen deposition by fibroblasts.
The rationale for combining these peptides is that tissue repair requires both vascular supply (BPC-157’s angiogenic activity) and cellular mobilization (TB-500’s migration-promoting activity) — two processes that must be coordinated for effective tissue regeneration. Published studies on each peptide individually demonstrate effects in overlapping tissue types (tendon, muscle, skin, cardiac) but through distinct molecular targets, suggesting the combination may produce additive or synergistic effects in research models.
Co-lyophilized with ≥99% purity per component. Store at -20°C desiccated. For tissue repair signaling research only.
BPC-157
Learn MoreTB-500 (Thymosin Beta-4 Acetate)
Learn MoreGLOW Blend (GHK-Cu + TB-500 + BPC-157)
Learn MoreGLOW Blend (GHK-Cu + TB-500 + BPC-157)
Learn MoreBPC-157 + TB-500 Blend
Learn MoreGHK-Cu (Copper Peptide)
Learn More